Study uncovers hidden proteins fueling heart disease and stroke

Researchers identified key proteins linked to cardiovascular disease, highlighting new targets for drug development using genetic and observational analyses in UK and China biobanks.

WHO warns global health toll of alcohol remains ‘unacceptably high’

The global health toll of alcohol remains “unacceptably high” across the globe, the World Health Organization said this week. Despite alcohol’s immense health toll, however,

June 25, 2024

FDA accepts Sanofi’s Sarclisa sBLA for priority review

In a Phase III trial, Sanofi’s Sarclisa regimen offered statistically significant PFS improvement in NDMM patients. Credit: Sergiy Palamarchuk/ Shutterstock.com. The US Food and Drug

May 28, 2024

Fast-Acting Spray for PSVT; Undiscounted Entresto’s Value; CTCA-Aided Angiography

Genome-wide association studies suggested some genetic overlap between schizophrenia and cardiovascular disease risk factors, particularly BMI and smoking. (American Journal of Psychiatry) People self-administering etripamil

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.